Evidence map›Paper›PMID 41551153›Full record

ArticleFrontiers in oncology2025

An enhanced YOLOv10 architecture for high-sensitivity and high-specificity lung cancer detection.

Liqun Li, Jing Guo, Yunfei Li, Chendong Li, Jiao Du

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liqun LiQingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Jing GuoQingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Yunfei LiDepartment of Research and Development, Huawei Technologies Co., Ltd, Nanjing, China.
Chendong LiQingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
Jiao DuQingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer detection using computed tomography (CT) imaging is a critical task for early diagnosis and improved patient outcomes. However, accurate identification of small and low-contrast pulmonary nodules remains challenging due to variations in nodule size, shape, and complex background interference. To overcome these challenges, we propose HARM-YOLO, an enhanced object detection framework based on YOLOv10, specifically designed for lung cancer detection in CT scans. Our model incorporates a multi-dimensional receptive field feature extractor (C2f-MDR), a decoupled neck architecture (DENeck), series and parallel receptive field enhancement modules (SRFEM and PRFEM), and a background attention mechanism to strengthen multi-scale feature representation and suppress irrelevant signals. Extensive experiments on the LIDC-IDRI and LUNA16 datasets demonstrate that HARM-YOLO achieves a mean average precision (mAP@0.5) of 91.3% and sensitivity of 92.7%, outperforming state-of-the-art methods including YOLOv5, ELCT-YOLO, and MSG-YOLO by significant margins. With an optimal balance of 92.7% sensitivity and 89.7% precision, our framework effectively detects true nodules while minimizing false positives, addressing key needs for computer-aided diagnosis in clinical screening. Furthermore, compared against segmentation-based approaches such as nnUNet and Swin-UNet, HARM-YOLO maintains superior performance on small nodules (≤6 mm) and real-time inference speed suitable for large-scale lung cancer screening programs. Our results highlight the potential of this YOLOv10-based object detection system as a robust and efficient tool for enhancing early lung cancer detection and supporting clinical decision-making.

Indexed as

computer-aided diagnosisCT imaginglung cancer detectionobject detectionYOLOv10

Identifiers

PMID41551153
PMCPMC12807957

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.